Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

2008. Paradis V, Laurendeau I, Vieillefond
A, Blanchet P, Eschwege P, Benoit G,
Vidaud M, Jardin A, Bedossa P (1998).
Clonal analysis of renal sporadic angiomyolipomas.
Hum Pathol 29: 1063-1067.
2009. Parham DM, Roloson GJ, Feely M,
Green DM, Bridge JA, Beckwith JB (2001).
Primary malignant neuroepithelial tumors
of the kidney: a clinicopathologic analysis
of 146 adult and pediatric cases from the
National Wilms’ Tumor Study Group
Pathology Center. Am J Surg Pathol 25:
133-146.
2010. Park S, Shinohara K, Grossfeld GD,
Carroll PR (2001). Prostate cancer detection
in men with prior high grade prostatic
intraepithelial neoplasia or atypical
prostate biopsy. J Urol 165: 1409-1414.
2011. Park SH, Kim TJ, Chi JG (1991).
Congenital granular cell tumor with systemic
involvement. Immunohistochemical
and ultrastructural study. Arch Pathol Lab
Med 115: 934-938.
2012. Parkin DM (2001). Global cancer statistics
in the year 2000. Lancet Oncol 2:
533-543.
2013. Parkin DM, Ferlay J, Hamdi-Cherif M,
Sitas F, Thomas JO, Wabinga H, Whelan
SL (2003). Cancer in Africa: Epidemiology
and Prevention. IARC Scientific
Publication No 153. IARC Press: Lyon.
2014. Parkin DM, Pisani P, Ferlay J (1999).
Estimates of the worldwide incidence of 25
major cancers in 1990. Int J Cancer 80:
827-841.
2015. Parkin DM, Pisani P, Lopez AD,
Masuyer E (1994). At least one in seven
cases of cancer is caused by smoking.
Global estimates for 1985. Int J Cancer 59:
494-504.
2016. Parkin DM, Whelan SL, Ferlay J,
Teppo L, Thomas DB (2003). Cancer
Incidence in Five Continents. IARC
Scientific Publications No155. IARC Press:
Lyon.
2017. Parkinson C, Harland SJ (1999).
Testis cancer. In: The Scientific Basis of
Urology, AR Mundy, JM Fitzpatrick, DE
Neal, NJR George, eds. ISIS Medical
Media: Oxford.
2018. Parkinson MC, Swerdlow AJ, Pike
MC (1994). Carcinoma in situ in boys with
cryptorchidism: when can it be detected?
Br J Urol 73: 431-435.
2019. Parmar MK, Freedman LS,
Hargreave TB, Tolley DA (1989).
Prognostic factors for recurrence and followup
policies in the treatment of superficial
bladder cancer: report from the British
Medical Research Council Subgroup on
Superficial Bladder Cancer (Urological
Cancer Working Party). J Urol 142: 284-
288.
2020. Parshad S, Yadav SP, Arora B (2001).
Urethral hemangioma. An unusual cause
of hematuria. Urol Int 66: 43-45.
2021. Partanen S, Asikainen U (1985). Oat
cell carcinoma of the urinary bladder with
ectopic adrenocorticotropic hormone production.
Hum Pathol 16: 313-315.
2022. Partin AW, Criley SR, Subong EN,
Zincke H, Walsh PC, Oesterling JE (1996).
Standard versus age-specific prostate
specific antigen reference ranges among
men with clinically localized prostate cancer:
A pathological analysis. J Urol 155:
1336-1339.
2023. Partin AW, Mangold LA, Lamm DM,
Walsh PC, Epstein JI, Pearson JD (2001).
Contemporary update of prostate cancer
staging nomograms (Partin Tables) for the
new millennium. Urology 58: 843-848.
2024. Parwani AV, Husain AN, Epstein JI,
Beckwith JB, Argani P (2001). Low-grade
myxoid renal epithelial neoplasms with distal
nephron differentiation. Hum Pathol 32:
506-512.
2025. Pashos CL, Botteman MF, Laskin BL,
Redaelli A (2002). Bladder cancer: epidemiology,
diagnosis, and management. Cancer
Pract 10: 311-322.
2026. Patsalis PC, Sismani C, Hadjimarcou
MI, Kitsiou-Tzeli S, Tzezou A,
Hadjiathanasiou CG, Velissariou V,
Lymberatou E, Moschonas NK, Skordis N
(1998). Detection and incidence of cryptic Y
chromosome sequences in Turner syndrome
patients. Clin Genet 53: 249-257.
2027. Pause A, Lee S, Lonergan KM,
Klausner RD (1998). The von Hippel-Lindau
tumor suppressor gene is required for cell
cycle exit upon serum withdrawal. Proc Natl
Acad Sci USA 95: 993-998.
2028. Pause A, Lee S, Worrell RA, Chen DY,
Burgess WH, Linehan WM, Klausner RD
(1997). The von Hippel-Lindau tumor-suppressor
gene product forms a stable complex
with human CUL-2, a member of the
Cdc53 family of proteins. Proc Natl Acad Sci
USA 94: 2156-2161.
2029. Pauwels RP, Smeets AW, Schapers
RF, Geraedts JP, Debruyne FM (1988).
Grading in superficial bladder cancer. (2).
Cytogenetic classification. Br J Urol 61: 135-
139.
2030. Pauwels RP, Smeets WW, Geraedts
JP, Debruyne FM (1987). Cytogenetic analysis
in urothelial cell carcinoma. J Urol 137:
210-215.
2031. Pavlovich CP, Glenn GM, Hewitt S
(2001). Renal tumours in the Birt-Hogg-Dube
syndrome: Disease spectrum and clinical
management. Am Urol Assoc Program
Abstracts 165: 159.
2032. Pavlovich CP, Schmidt LS, Phillips JL
(2003). The genetic basis of renal cell carcinoma.
Urol Clin North Am 30: 437-454.
2033. Pavlovich CP, Walther MM, Eyler RA,
Hewitt SM, Zbar B, Linehan WM, Merino MJ
(2002). Renal tumors in the Birt-Hogg-Dube’
syndrome. Am J Surg Pathol 26: 1542-1552.
2034. Pawade J, Banerjee SS, Harris M,
Isaacson P, Wright D (1993). Lymphomas of
mucosa-associated lymphoid tissue arising
in the urinary bladder. Histopathology 23:
147-151.
2035. Pawade J, Soosay GN, Delprado W,
Parkinson MC, Rode J (1993). Cystic hamartoma
of the renal pelvis. Am J Surg Pathol
17: 1169-1175.
2036. Pea M, Bonetti F, Martignoni G,
Henske EP, Manfrin E, Colato C, Bernstein J
(1998). Apparent renal cell carcinomas in
tuberous sclerosis are heterogeneous: the
identification of malignant epithelioid
angiomyolipoma. Am J Surg Pathol 22: 180-
187.
2037. Pea M, Bonetti F, Zamboni G,
Martignoni G, Riva M, Colombari R,
Mombello A, Bonzanini M, Scarpa A,
Ghimenton C, Donati LF (1991). Melanocytemarker-HMB-45
is regularly expressed in
angiomyolipoma of the kidney. Pathology 23:
185-188.
2038. Pearson JM, Banerjee SS, Haboubi NY
(1989). Two cases of pseudosarcomatous
invasive transitional cell carcinoma of the
urinary bladder mimicking malignant fibrous
histiocytoma. Histopathology 15: 93-96.
2039. Pedersen-Bjergaard J, Jonsson V,
Pedersen M, Hou-Jensen K (1995).
Leiomyosarcoma of the urinary bladder
after cyclophosphamide. J Clin Oncol 13:
532-533.
2040. Pedersen KV, Boiesen P, Zetterlund CG
(1987). Experience of screening for carcinoma-in-situ
of the testis among young men
with surgically corrected maldescended
testes. Int J Androl 10: 181-185.
2041. Peison B, Benisch B, Nicora B (1985).
Multicentric basal cell carcinoma of penile
skin. Urology 25: 322-323.
2042. Pelkey TJ, Frierson HFJr, Mills SE,
Stoler MH (1999). Detection of the alpha-subunit
of inhibin in trophoblastic neoplasia. Hum
Pathol 30: 26-31.
2043. Pelletier J, Bruening W, Kashtan CE,
Mauer SM, Manivel JC, Striegel JE,
Houghton DC, Junien C, Habib R, Fouser L,
Fine RN, Silverman BL, Haber DA, Housman
DE (1991). Germline mutations in the Wilms’
tumor suppressor gene are associated with
abnormal urogenital development in Denys-
Drash syndrome. Cell 67: 437-447.
2044. Peltomaki P, Lothe RA, Aaltonen LA,
Pylkkanen L, Nystrom-Lahti M, Seruca R,
David L, Holm R, Ryberg D, Haugen A,
Brogger A, Borresen AL, de la Chapelle A
(1993). Microsatellite instability is associated
with tumors that characterize the hereditary
non-polyposis colorectal carcinoma syndrome.
Cancer Res 53: 5853-5855.
2045. Peng HQ, Liu L, Goss PE, Bailey D, Hogg
D (1999). Chromosomal deletions occur in
restricted regions of 5q in testicular germ cell
cancer. Oncogene 18: 3277-3283.
2046. Perachino M, di Ciolo L, Barbetti V,
Ardoino S, Vitali A, Introini C, Vigliercio G,
Puppo P (1997). Results of rebiopsy for suspected
prostate cancer in symptomatic men
with elevated PSA levels. Eur Urol 32: 155-
159.
2047. Peralta-Venturina M, Moch H, Amin M,
Tamboli P, Hailemariam S, Mihatsch M,
Javidan J, Stricker H, Ro JY, Amin MB (2001).
Sarcomatoid differentiation in renal cell carcinoma:
a study of 101 cases. Am J Surg
Pathol 25: 275-284.
2048. Perez-Atayde AR, Joste N, Mulhern H
(1996). Juvenile granulosa cell tumor of the
infantile testis. Evidence of a dual epithelialsmooth
muscle differentiation. Am J Surg
Pathol 20: 72-79.
2049. Perez-Mesa C, Oxenhandler R (1989).
Metastatic tumors of the penis. J Surg Oncol
42: 11-15.
2050. Perez-Ordonez B, Hamed G, Campbell
S, Erlandson RA, Russo P, Gaudin PB, Reuter
VE (1997). Renal oncocytoma: a clinicopathologic
study of 70 cases. Am J Surg Pathol 21:
871-883.
2051. Perez-Ordonez B, Srigley JR (2000).
Mesothelial lesions of the paratesticular
region. Semin Diagn Pathol 17: 294-306.
2052. Perez C, Novoa J, Alcaniz J, Salto L,
Barcelo B (1980). Leydig cell tumour of the
testis with gynaecomastia and elevated
oestrogen, progesterone and prolactin levels:
case report. Clin Endocrinol (Oxf) 13: 409-412.
2053. Perito PE, Ciancio G, Civantos F,
Politano VA (1992). Sertoli-Leydig cell testicular
tumor: case report and review of sex
cord/gonadal stromal tumor histogenesis. J
Urol 148: 883-885.
2054. Perlman EJ, Hu J, Ho D, Cushing B,
Lauer S, Castleberry RP (2000). Genetic
analysis of childhood endodermal sinus
tumors by comparative genomic hybridization.
J Pediatr Hematol Oncol 22: 100-105.
2055. Pero R, Lembo F, di Vizio D, Boccia A,
Chieffi P, Fedele M, Pierantoni GM, Rossi P,
Iuliano R, Santoro M, Viglietto G, Bruni CB,
Fusco A, Chiariotti L (2001). RNF4 is a growth
inhibitor expressed in germ cells but not in
human testicular tumors. Am J Pathol 159:
1225-1230.
2056. Perou CM, Sorlie T, Eisen MB, van de
Rijn M, Jeffrey SS, Rees CA, Pollack JR,
Ross DT, Johnsen H, Akslen LA, Fluge O,
Pergamenschikov A, Williams C, Zhu SX,
Lonning PE, Borresen-Dale AL, Brown PO,
Botstein D (2000). Molecular portraits of
human breast tumours. Nature 406: 747-752.
2057. Perret L, Chaubert P, Hessler D,
Guillou L (1998). Primary heterologous carcinosarcoma
(metaplastic carcinoma) of
the urinary bladder: a clinicopathologic,
immunohistochemical, and ultrastructural
analysis of eight cases and a review of the
literature. Cancer 82: 1535-1549.
2058. Pesti T, Sukosd F, Jones EC, Kovacs G
(2001). Mapping a tumor suppressor gene
to chromosome 2p13 in metanephric adenoma
by microsatellite allelotyping. Hum
Pathol 32: 101-104.
2059. Petersen I, Ohgaki H, Ludeke BI,
Kleihues P (1993). p53 mutations in
phenacetin-associated human urothelial
carcinomas. Carcinogenesis 14: 2119-2122.
2060. Petersen SE, Harving N, Orntoft T,
Wolf H (1988). Clonal heterogeneity of aneuploid
cell populations in carcinoma in situ
of the bladder: a flow cytometric study.
Scand J Urol Nephrol Suppl 110: 213-217.
2061. Pettijohn DE, Stranahan PL, Due C,
Ronne E, Sorensen HR, Olsson L (1987).
Glycoproteins distinguishing non-small cell
from small cell human lung carcinoma recognized
by monoclonal antibody 43-9F.
Cancer Res 47: 1161-1169.
2062. Pettinato G, Manivel JC, d’Amore ES,
Jaszcz W, Gorlin RJ (1991). Melanotic neuroectodermal
tumor of infancy. A reexamination
of a histogenetic problem based on
immunohistochemical, flow cytometric,
and ultrastructural study of 10 cases. Am J
Surg Pathol 15: 233-245.
2063. Pettinato G, Manivel JC, Wick MR,
Dehner LP (1989). Classical and cellular
(atypical) congenital mesoblastic nephroma:
a clinicopathologic, ultrastructural,
immunohistochemical, and flow cytometric
study. Hum Pathol 20: 682-690.
2064. Peyromaure M, Weibing S, Sebe P,
Verpillat P, Toublanc M, Dauge MC,
Boccon-Gibod L, Ravery V (2002).
Prognostic value of p53 overexpression in
T1G3 bladder tumors treated with bacillus
Calmette-Guerin therapy. Urology 59: 409-
413.
2065. Pfister C, Buzelin F, Casse C,
Bochereau G, Buzelin JM, Bouchot O
(1998). Comparative analysis of MiB1 and
p53 expression in human bladder tumors
and their correlation with cancer progression.
Eur Urol 33: 278-284.
2066. Pfister C, Flaman JM, Martin C, Grise
P, Frebourg T (1999). Selective detection of
inactivating mutations of the tumor suppressor
gene p53 in bladder tumors. J Urol
161: 1973-1975.
2067. Pfister C, Larue H, Moore L, Lacombe
L, Veilleux C, Tetu B, Meyer F, Fradet Y
(2000). Tumorigenic pathways in low-stage
bladder cancer based on p53, MDM2 and
p21 phenotypes. Int J Cancer 89: 100-104.
2068. Pfister C, Moore L, Allard P, Larue H,
Lacombe L, Tetu B, Meyer F, Fradet Y
(1999). Predictive value of cell cycle markers
p53, MDM2, p21, and Ki-67 in superficial
bladder tumor recurrence. Clin Cancer Res
5: 4079-4084.
2069. Philip AT, Amin MB, Tamboli P, Lee
TJ, Hill CE, Ro JY (2000). Intravesical adipose
tissue: a quantitative study of its presence
and location with implications for
therapy and prognosis. Am J Surg Pathol
24: 1286-1290.
References 337